ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma GlobeNewswire November 04, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In ATyr To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $10,000 in ATyr […]
(NYSE:MOH), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Molina To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $10,000 in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi &
MOH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare GlobeNewswire November 04, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Molina To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $10,000 in Molina
IgniteData, a leader in intelligent clinical trial data automation, today announced the final close of its oversubscribed Series A funding round. This close brings the total capital raised in the round to $11M, fueling IgniteData's expansion of its global research site network, advancement of its flagship product, Archer, and acceleration of innovation in generative AI-powered
“I wanted to provide police with a safe and effective means of keeping a vehicle stopped along the roadside when a motorist is suspected of criminal activity,” said an inventor, from San Diego, Calif., “so I invented THE STOPPER. My design would keep the car from speeding off, thereby avoiding high-speed chase situations.” https://mma.prnewswire.com/media/2099578/InventHelp_Logo_jpg_Logo.jpg The
(Euronext Growth Paris:ALGBE), PRESS RELEASE Global Bioenergies: postponement of the takeover offers review hearing to 24 November Evry, 04 November 2025 – 05:45 p.m: The hearing which was held yesterday at the Commercial Court of Evry concluded with the decision to postpone until 24 November 2025 the review of the offers to take over Global
(Paris:TNG), New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050's ability to induce neoantigen-specific cytotoxic CD8+ T cell responses capable of targeting and eliminating tumor cells, supporting its potential to reduce risk of relapse Conference call scheduled on
Global Bioenergies: postponement of the takeover offers review hearing to 24 November GlobeNewswire November 04, 2025 PRESS RELEASE Global Bioenergies: postponement of the takeover offers review hearing to 24 November Evry, 04 November 2025 – 05:45 p.m: The hearing which was held yesterday at the Commercial Court of Evry concluded with the decision to postpone
New Phase I Immunological Data Presented at SITC 2025 Support TG4050's Potential Role in Preventing Cancer Relapse GlobeNewswire November 04, 2025 New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050's ability to induce neoantigen-specific cytotoxic CD8+ T cell
(Other OTC:NJDCY), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Nidec To Contact Him Directly To Discuss Their Options If you suffered significant losses in Nidec stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at